Literature DB >> 8334681

Overexpression of 27-kDa heat-shock protein in MCF-7 breast cancer cells: effects on lymphocyte-mediated killing by natural killer and gamma delta T cells.

D M Mahvi1, S W Carper, F K Storm, S R Teal, P M Sondel.   

Abstract

Overexpression of the heat-shock protein hsp27 protein in primary breast cancers has been associated with early relapse in women with breast cancer. This study was designed to determine the role of the hsp27 protein in lymphocyte recognition of estrogen-receptor(ER)-positive breast cancer cells and to assess the effect of hsp27 expression on lymphocyte-mediated lysis. The hsp27 cDNA was inserted into the pHbAPr-1-neo plasmid expression vector and driven by the constitutive actin promoter. The ER-positive MCF-7 human breast cancer cell line was then transfected with this vector and the resulting clonal cell lines were confirmed to overexpress hsp27. hsp27-transfected clonal cell lines stimulated the proliferation of fresh peripheral blood lymphocytes (PBL) significantly better than control cells transfected with the expression vector alone. When clonal gamma delta T cell lines were utilized as effectors, hsp27-transfected cell lines were significantly better targets for lysis than a control-transfected MCF-7 cell line. In contrast, hsp27-transfected cell lines had no increase in susceptibility to lymphokine-activated-killer- or natural-killer-mediated lysis. These results suggest that overexpression of the hsp27 protein in ER-positive MCF-7 cells stimulated the proliferation of fresh PBL and the lysis of MCF-7 cells by gamma delta T cell clones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8334681     DOI: 10.1007/bf01525433

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  cDNA sequence of a human heat shock protein HSP27.

Authors:  S W Carper; T A Rocheleau; F K Storm
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

2.  Dynamic changes in the structure and intracellular locale of the mammalian low-molecular-weight heat shock protein.

Authors:  A P Arrigo; J P Suhan; W J Welch
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

3.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue.

Authors:  D R Ciocca; A O Stati; M M Amprino de Castro
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

5.  Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx).

Authors:  C Gambacorti-Passerini; L Rivoltini; R Supino; M Mariani; G Parmiani
Journal:  Int J Cancer       Date:  1988-10-15       Impact factor: 7.396

6.  Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations.

Authors:  A Thor; C Benz; D Moore; E Goldman; S Edgerton; J Landry; L Schwartz; B Mayall; E Hickey; L A Weber
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

7.  Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.

Authors:  J Huot; G Roy; H Lambert; P Chrétien; J Landry
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

8.  The standardization of NK cell assays for use in studies of biological response modifiers.

Authors:  H F Pross; J A Maroun
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

9.  Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complex-restricted cytolysis.

Authors:  P Fisch; M Malkovsky; E Braakman; E Sturm; R L Bolhuis; A Prieve; J A Sosman; V A Lam; P M Sondel
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells.

Authors:  G De Libero; G Casorati; C Giachino; C Carbonara; N Migone; P Matzinger; A Lanzavecchia
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

View more
  6 in total

1.  RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.

Authors:  Jörg-Christian Heinrich; Anne Tuukkanen; Michael Schroeder; Torsten Fahrig; Rudolf Fahrig
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-22       Impact factor: 4.553

Review 2.  The enigmatic specificity of gamma delta T cells.

Authors:  B C Weintraub; S M Hedrick
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Overexpression of Hsp25 in K1735 murine melanoma cells enhances susceptibility to natural killer cytotoxicity.

Authors:  Christian Jantschitsch; Franz Trautinger; Gabriele Klosner; Andrea Gsur; Irene Herbacek; Michael Micksche; Ingela Kindås-Mügge
Journal:  Cell Stress Chaperones       Date:  2002-01       Impact factor: 3.667

4.  Mice that overexpress human heat shock protein 27 have increased renal injury following ischemia reperfusion.

Authors:  Sean W C Chen; Minjae Kim; Mihwa Kim; Joseph H Song; Sang Won Park; Dominic Wells; Kevin Brown; Jacqueline de Belleroche; Vivette D D'Agati; H Thomas Lee
Journal:  Kidney Int       Date:  2008-11-19       Impact factor: 10.612

5.  Suppression of cytotoxic T lymphocyte activity by gamma/delta T cells in tumor-bearing mice.

Authors:  N Seo; K Egawa
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

6.  Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Authors:  M J Maeurer; D Martin; W Walter; K Liu; L Zitvogel; K Halusczcak; H Rabinowich; R Duquesnoy; W Storkus; M T Lotze
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.